← Back to Search

Behavioral Intervention

Individualized Assess & Treatment (IATP) for Alcoholism (IATP2 Trial)

N/A
Waitlist Available
Led By Mark D Litt
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 6 months from intake through 21 months
Awards & highlights

IATP2 Trial Summary

This trial is testing a new treatment for alcohol use disorders that uses cellphones to collect data in real-time and direct treatment for each patient based on their individual patterns of drinking.

IATP2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 6 months from intake through 21 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 months from intake through 21 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of days abstinent (PDA)
Secondary outcome measures
Drinker Inventory of Consequences (DrInC) score
Proportion Heavy Drinking days (PDH)

IATP2 Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Individualized Assess & Treatment (IATP)Experimental Treatment1 Intervention
Intervention: Cognitive-Behavioral IATP consists of 12 weekly visits of individual treatment. IATP employs cellphone-based experience sampling via interactive voice response (IVR) to assess drinking, plus craving, thoughts, feelings, and coping behaviors to develop near a real-time picture of patients' high-risk situations and the ways they use to deal with them. This information will be used by the therapist and client together to problem-solve and devise adaptive coping responses to these specific high-risk situations, and develop generalized solutions to deal with other situations in the future.
Group II: Case Management (CaseM)Active Control1 Intervention
Intervention: Social and Instrumental Support CaseM is included to control for cohort and other common factors in treatment. During the 12 individual CaseM sessions the therapist and participant will identify problems in daily living that may be of concern, and consider community resources that might help in dealing with them (e.g., contacting a psychiatrist for depression, or finding a better place to live). The therapist's role is to explore the patient's concerns, help to identify goals and resources, provide verbal support, and troubleshoot difficulties that may arise in obtaining or following through with services. The support and attention to ancillary services has proven effective in reducing drinking in previous studies.
Group III: Packaged Cognitive-Behavioral (PCBT)Active Control1 Intervention
Intervention: Cognitive-Behavioral PCBT consists of 12 weekly visits of individual treatment. PCBT is designed to remediate deficits in skills for coping with interpersonal (e.g., social pressure, conflict with others) and intrapersonal (e.g., craving, anger) antecedents to drinking. The treatment consists of 6 mandatory modules (e.g., managing cravings) plus 6 electives from a list of 10 (e.g., receiving criticism; scheduling pleasant activities).The treatment, based on manuals developed for our previous clinical research provides a structured experience using didactic presentations, behavioral rehearsal, and homework practice exercises.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Individualized Assess & Treatment (IATP)
2016
N/A
~180

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor
211 Previous Clinical Trials
60,448 Total Patients Enrolled
19 Trials studying Alcoholism
3,379 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,365,272 Total Patients Enrolled
424 Trials studying Alcoholism
985,695 Patients Enrolled for Alcoholism
Mark D LittPrincipal InvestigatorUConn Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people suffering from the target ailment able to participate in this research project at this time?

"According to the latest update on clinicaltrials.gov, this trial is no longer looking for patients. It was first posted on 8/1/2016, with the last update on 10/31/2022. Although this study is not enrolling candidates anymore, there are 268 other trials actively recruiting participants at this time."

Answered by AI
~20 spots leftby Apr 2025